The Cooper Companies, Inc. (NASDAQ:COO) Shares Purchased by Navellier & Associates Inc.

Navellier & Associates Inc. boosted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 30.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,168 shares of the medical device company’s stock after acquiring an additional 975 shares during the period. Navellier & Associates Inc.’s holdings in Cooper Companies were worth $383,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. Sequoia Financial Advisors LLC lifted its stake in Cooper Companies by 15.3% during the third quarter. Sequoia Financial Advisors LLC now owns 4,272 shares of the medical device company’s stock worth $471,000 after purchasing an additional 568 shares in the last quarter. International Assets Investment Management LLC acquired a new position in Cooper Companies during the third quarter worth $46,727,000. Allworth Financial LP lifted its stake in Cooper Companies by 45.8% during the third quarter. Allworth Financial LP now owns 968 shares of the medical device company’s stock worth $107,000 after purchasing an additional 304 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in Cooper Companies by 25.0% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 17,833 shares of the medical device company’s stock worth $1,958,000 after purchasing an additional 3,566 shares in the last quarter. Finally, Forsta AP Fonden lifted its stake in Cooper Companies by 3.0% during the third quarter. Forsta AP Fonden now owns 41,600 shares of the medical device company’s stock worth $4,590,000 after purchasing an additional 1,200 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Trading Down 0.2 %

NASDAQ:COO opened at $88.48 on Monday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock has a market capitalization of $17.66 billion, a price-to-earnings ratio of 45.37, a PEG ratio of 2.25 and a beta of 1.00. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38. The stock has a fifty day moving average price of $92.94 and a two-hundred day moving average price of $99.66.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.04. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Cooper Companies’s revenue was up 9.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.87 earnings per share. As a group, sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Wells Fargo & Company increased their target price on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Citigroup reduced their price objective on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Finally, Morgan Stanley cut their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, Cooper Companies presently has a consensus rating of “Moderate Buy” and an average price target of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.